drugset / Trial / NCT05653310

Tradipitant for Functional Dyspepsia

NCT05653310

Phase 2 Enrolling by invitation 60 enrolled Xiao Jing (Iris) Wang Mayo Clinic · collab
RandomizedParallel-groupQuadruple-blindBasic science

Summary

To evaluate the effects of tradipitant relative to placebo on gastric motor functions, satiation, and postprandial symptoms in patients with functional dyspepsia.

Timeline

Start
2023-02-09
Primary completion
2027-03
Completion
2027-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Tradipitant Small molecule Oral

Indications